Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (79)

2024

  1. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

  2. ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload

    Communications Biology, Vol. 5, Núm. 1

  3. Heart failure in chronic kidney disease: The emerging role of myocardial fibrosis

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 5, pp. 817-824

2021

  1. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

2020

  1. Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)

    Scientific Reports

  2. Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease

    Journal of hypertension, Vol. 38, Núm. 10, pp. 2036-2042

  3. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers

    Open Heart, Vol. 7, Núm. 1

  5. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction

    Circulation, Vol. 141, Núm. 9, pp. 751-767

2019

  1. Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

    Journal of Cardiovascular Electrophysiology, Vol. 30, Núm. 8, pp. 1231-1240

  2. Circulating biomarkers predicting longitudinal changes in left ventricular structure and function in a general population

    Journal of the American Heart Association, Vol. 8, Núm. 2

  3. Circulating long noncoding RNA LIPCAR Predicts heart failure outcomes in patients without chronic kidney disease

    Hypertension, Vol. 73, Núm. 4, pp. 820-828

  4. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1398-1410

  5. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

    Heart, Vol. 105, Núm. 4, pp. 307-314

2018

  1. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis

    FASEB Journal, Vol. 32, Núm. 11, pp. 6066-6078

  2. Reappraising myocardial fibrosis in severe aortic stenosis: An invasive and non-invasive study in 133 patients

    European Heart Journal, Vol. 39, Núm. 8, pp. 699-709

  3. Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis

    Journal of the American College of Cardiology, Vol. 71, Núm. 8, pp. 860-871

2017

  1. A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population

    Kidney International Reports, Vol. 2, Núm. 5, pp. 811-820

  2. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2